Kenyan President William Ruto announced on Thursday that a $500 million mRNA vaccine facility will be built in Nairobi by the US biotech company Moderna. At a regional trade summit sponsored by the American Chamber of Commerce, Ruto declared,...
French pharmaceutical firm Sanofi has started a process to demerge its consumer healthcare division in India into a listed company...
ViiV Healthcare, a joint venture of GSK, Pfizer, and Shionogi, and the UN's Medicine Patent Pool (MPP) granted Aurobindo, Cipla, and Viatris sub-licenses to manufacture generic versions of the HIV preventive therapy cabotegravir long-acting...
Prelude Corporation, a pioneer in molecular diagnostics and precision medicine for early-stage breast cancer, announced that the DCISionRT test has been granted Advanced Diagnostic Laboratory Test (ADLT) status by the Centers for Medicare &....
Granules India Ltd announced on Wednesday that the US Food and Drug Administration has approved its generic gabapentin tablets for the treatment of postherpetic neuralgia in adults. The US Food and Drug Administration (USFDA) has approved an...
JB Chemicals & Pharmaceuticals (JB Pharma) CEO Nikhil Chopra stated that the company is looking into possible acquisitions of brands and portfolios in order to gain a foothold in the diabetes segment. "In the world of metabolics, we'd like to...
Beta Drugs Ltd (Adley Group) has received approval from the Drug Controller General of India (DCGI) to market Enzalutamide 160 mg under the brand name ADLEAP. This medicine was developed by the company to provide a much-needed treatment option for...
Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that the US Food and Drug Administration (FDA) accepted Delcath's (Delcath) new drug application resubmission for...
The Central Drugs Standard Control Organization has granted Sanofi (India) marketing authorization for their diabetes medicine Soliqua (in pre-filled pen). (CDSCO)....
Drug development is a very complex process that takes years and costs billions of dollars. According to the Tufts Center for the Study of Drug Development, the average cost of developing a new drug is $2.6 billion, and it takes an average of 10 years
, CDSCO.jpg)
